Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.

Zhao D, Kim YH, Jeong S, Greenson JK, Chaudhry MS, Hoepting M, Anderson ER, van den Brink MR, Peled JU, Gomes AL, Slingerland AE, Donovan MJ, Harris AC, Levine JE, Ozbek U, Hooper LV, Stappenbeck TS, Ver Heul A, Liu TC, Reddy P, Ferrara JL.

J Clin Invest. 2018 Nov 1;128(11):4970-4979. doi: 10.1172/JCI99261. Epub 2018 Sep 24.

2.

The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation.

Weber D, Frauenschläger K, Ghimire S, Peter K, Panzer I, Hiergeist A, Weber M, Kutny D, Wolff D, Grube M, Huber E, Oefner P, Gessner A, Hehlgans T, Herr W, Holler E.

PLoS One. 2017 Sep 21;12(9):e0185265. doi: 10.1371/journal.pone.0185265. eCollection 2017.

3.

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Huber E, Landfried K, Akashi K, Vander Lugt M, Reddy P, Chin A, Zhang Q, Hanash S, Paczesny S.

Blood. 2011 Dec 15;118(25):6702-8. doi: 10.1182/blood-2011-08-375006. Epub 2011 Oct 6.

4.

Acute Graft-versus-Host Disease: Novel Biological Insights.

Teshima T, Reddy P, Zeiser R.

Biol Blood Marrow Transplant. 2016 Jan;22(1):11-6. doi: 10.1016/j.bbmt.2015.10.001. Epub 2015 Oct 26. Review.

5.

T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation.

Fu YY, Egorova A, Sobieski C, Kuttiyara J, Calafiore M, Takashima S, Clevers H, Hanash AM.

Immunity. 2019 Jul 16;51(1):90-103.e3. doi: 10.1016/j.immuni.2019.06.003. Epub 2019 Jul 2.

PMID:
31278057
6.

Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.

Kawakami K, Minami N, Matsuura M, Iida T, Toyonaga T, Nagaishi K, Arimura Y, Fujimiya M, Uede T, Nakase H.

Biochem Biophys Res Commun. 2017 Apr 1;485(2):468-475. doi: 10.1016/j.bbrc.2017.02.047. Epub 2017 Feb 9.

7.

[Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].

Cai CS, Chen GH, Sun AN, Qiao M, Liu HW, Chen F, Wang Y, Qiu HY, Han Y, Ma X, Tang XW, Jin ZM, Fu CC, Wu DP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):785-90. doi: 10.7534/j.issn.1009-2137.2014.03.039. Chinese.

PMID:
24989295
8.

Have we made progress in the treatment of GVHD?

Harris AC, Levine JE, Ferrara JL.

Best Pract Res Clin Haematol. 2012 Dec;25(4):473-8. doi: 10.1016/j.beha.2012.10.010. Epub 2012 Oct 25. Review.

9.

The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.

Takashima S, Kadowaki M, Aoyama K, Koyama M, Oshima T, Tomizuka K, Akashi K, Teshima T.

J Exp Med. 2011 Feb 14;208(2):285-94. doi: 10.1084/jem.20101559. Epub 2011 Jan 31.

10.

Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights.

Teshima T, Reddy P, Zeiser R.

Biol Blood Marrow Transplant. 2016 Mar;22(3 Suppl):S3-8. doi: 10.1016/j.bbmt.2016.01.004. Review.

11.

Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.

Lindemans CA, Calafiore M, Mertelsmann AM, O'Connor MH, Dudakov JA, Jenq RR, Velardi E, Young LF, Smith OM, Lawrence G, Ivanov JA, Fu YY, Takashima S, Hua G, Martin ML, O'Rourke KP, Lo YH, Mokry M, Romera-Hernandez M, Cupedo T, Dow L, Nieuwenhuis EE, Shroyer NF, Liu C, Kolesnick R, van den Brink MRM, Hanash AM.

Nature. 2015 Dec 24;528(7583):560-564. doi: 10.1038/nature16460. Epub 2015 Dec 9.

12.

Non-invasive diagnosis of acute intestinal graft-versus-host disease by a new scoring system using ultrasound morphology, compound elastography, and contrast-enhanced ultrasound.

Weber D, Weber M, Hippe K, Ghimire S, Wolff D, Hahn J, Evert M, Herr W, Holler E, Jung EM.

Bone Marrow Transplant. 2019 Jul;54(7):1038-1048. doi: 10.1038/s41409-018-0381-4. Epub 2018 Nov 6.

PMID:
30401964
13.

Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

Harris AC, Ferrara JL, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Landfried K, Akashi K, Vander Lugt M, Couriel DR, Reddy P, Paczesny S.

Blood. 2012 Mar 22;119(12):2960-3. doi: 10.1182/blood-2011-10-387357. Epub 2012 Jan 27.

14.

Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.

Cruz-Correa M, Poonawala A, Abraham SC, Wu TT, Zahurak M, Vogelsang G, Kalloo AN, Lee LA.

Endoscopy. 2002 Oct;34(10):808-13.

PMID:
12244503
15.

Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.

Melson J, Jakate S, Fung H, Arai S, Keshavarzian A.

Am J Hematol. 2007 Oct;82(10):881-6.

16.

Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality.

Levine JE, Huber E, Hammer ST, Harris AC, Greenson JK, Braun TM, Ferrara JL, Holler E.

Blood. 2013 Aug 22;122(8):1505-9. doi: 10.1182/blood-2013-02-485813. Epub 2013 Jun 12.

17.

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, Ferrara JL.

J Clin Invest. 1999 Aug;104(3):317-25.

18.

Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.

Xing S, Zhang X, Liu JH, Huang X, Zhou P.

Clin Exp Immunol. 2019 Jan;195(1):121-131. doi: 10.1111/cei.13215. Epub 2018 Oct 14.

PMID:
30317551
19.

Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.

Li Y, Chen HL, Bannick N, Henry M, Holm AN, Metwali A, Urban JF Jr, Rothman PB, Weiner GJ, Blazar BR, Elliott DE, Ince MN.

J Immunol. 2015 Feb 1;194(3):1011-20. doi: 10.4049/jimmunol.1303099. Epub 2014 Dec 19.

20.

Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC Trial.

Greuter T, Lang S, Holler E, Hawkey CJ, Rogler G, Biedermann L; ASTIC trial group.

Digestion. 2015;92(2):83-9. doi: 10.1159/000437300. Epub 2015 Aug 1.

Supplemental Content

Support Center